12 Affordable Biotech Stocks to Invest In Now

Page 4 of 11

8. Innoviva, Inc. (NASDAQ:INVA)

Forward P/E: 10.76

Number of Hedge Fund Holders: 26

Innoviva, Inc. (NASDAQ:INVA) is one of the best affordable biotech stocks to invest in now. On August 11, H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on Innoviva, Inc. (NASDAQ:INVA) to $45 from $40 while keeping a Buy rating on the shares.

The same day, Oppenheimer initiated coverage of Innoviva, Inc. (NASDAQ:INVA) with an Outperform rating and $35 price target.

The firm told investors that it considers Innoviva, Inc.’s (NASDAQ:INVA) specialty therapeutics and royalty commercial results to be significant factors that can drive share outperformance.

Innoviva, Inc. (NASDAQ:INVA) is involved in the development, commercialization, and financial management of biopharmaceuticals.

Page 4 of 11